| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.87B | 20.55B | 20.65B | 18.32B | 17.02B | 16.29B |
| Gross Profit | 7.62B | 7.87B | 7.75B | 6.73B | 6.16B | 5.39B |
| EBITDA | 3.69B | 4.02B | 4.12B | 3.63B | 3.39B | 2.53B |
| Net Income | 2.72B | 2.91B | 2.77B | 2.29B | 2.11B | 1.68B |
Balance Sheet | ||||||
| Total Assets | 23.06B | 24.30B | 24.35B | 21.85B | 20.01B | 18.91B |
| Cash, Cash Equivalents and Short-Term Investments | 13.71B | 12.78B | 13.96B | 13.15B | 12.74B | 10.72B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 4.39B | 5.26B | 5.52B | 4.68B | 4.40B | 4.81B |
| Stockholders Equity | 18.67B | 19.04B | 18.84B | 17.17B | 15.61B | 14.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.33B | 2.43B | 1.17B | 2.45B | 2.42B |
| Operating Cash Flow | 0.00 | 2.61B | 2.84B | 1.71B | 2.81B | 2.73B |
| Investing Cash Flow | 0.00 | -2.51B | -504.35M | -758.78M | -353.47M | -429.13M |
| Financing Cash Flow | 0.00 | -2.67B | -1.62B | -744.37M | -544.86M | -526.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥43.49B | 15.76 | ― | 3.28% | -3.21% | 8.89% | |
74 Outperform | ¥51.00B | 12.74 | ― | 2.82% | 10.46% | 8.98% | |
73 Outperform | ¥46.48B | 18.47 | 17.50% | 2.88% | 5.62% | 3.81% | |
72 Outperform | ¥30.71B | 13.94 | ― | 3.40% | 12.64% | 30.73% | |
65 Neutral | ¥31.25B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |